Susquehanna International Group, LLP Ptc Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 101,669 shares of PTCT stock, worth $5.72 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101,669
Previous 22,142
359.17%
Holding current value
$5.72 Million
Previous $821,000
458.95%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding PTCT
# of Institutions
257Shares Held
72.6MCall Options Held
179KPut Options Held
536K-
Vanguard Group Inc Valley Forge, PA9.18MShares$516 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$437 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$416 Million5.44% of portfolio
-
Armistice Capital, LLC New York, NY6.38MShares$359 Million4.07% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.29MShares$185 Million0.24% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $4.03B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...